Alamar Biosciences Q3 EPS $(0.19); Sales $33.55M Up 68% From $19.91M YoY
Benzinga Newsdesk 17 hours ago
NewsEarningsEarnings Beats
Alamar Biosciences (NASDAQ:ALMR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. The company reported quarterly sales of $33.550 million which beat
Alamar Biosciences (NASDAQ:ALMR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. The company reported quarterly sales of $33.550 million which beat the analyst consensus estimate of $30.187 million by 11.14 percent.